P27577
Gene name |
Ets1 (Ets-1) |
Protein name |
Protein C-ets-1 |
Names |
p54 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:23871 |
EC number |
|
Protein Class |
ETS (PTHR11849) |

Descriptions
Ets1 is a transcription factor directly controlling the expression of cytokine and chemokine genes in a wide variety of different cellular contexts. Truncation of either the N-terminal inhibitory region (residues 280-330) or the C-terminal inhibitory region (residues 416-440) increases the DNA binding affinity of Ets-1 by 10- to 20-fold, indicating that the two inhibitory regions act in concert to impair DNA binding
Autoinhibitory domains (AIDs)
Target domain |
331-415 (ETS domain) |
Relief mechanism |
Partner binding |
Assay |
Deletion assay, Mutagenesis experiment, Structural analysis |
Target domain |
331-415 (ETS domain) |
Relief mechanism |
Partner binding |
Assay |
Deletion assay, Mutagenesis experiment, Structural analysis |
Accessory elements
No accessory elements
References
- Garvie CW et al. (2002) "Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships", The Journal of biological chemistry, 277, 45529-36
- Nelson ML et al. (2010) "Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP", Proceedings of the National Academy of Sciences of the United States of America, 107, 10026-31
- Ning S et al. (2022) "The auto-inhibition mechanism of transcription factor Ets-1 induced by phosphorylation on the intrinsically disordered region", Computational and structural biotechnology journal, 20, 1132-1141
Autoinhibited structure
Activated structure
11 structures for P27577
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
1K78 | X-ray | 225 A | B/F | 331-440 | PDB |
1K79 | X-ray | 240 A | A/D | 331-440 | PDB |
1K7A | X-ray | 280 A | A/D | 331-440 | PDB |
1MD0 | X-ray | 200 A | A/B | 300-440 | PDB |
1MDM | X-ray | 280 A | B | 280-440 | PDB |
1R36 | NMR | - | A | 301-440 | PDB |
2JV3 | NMR | - | A | 29-138 | PDB |
2KMD | NMR | - | A | 29-138 | PDB |
6DA1 | X-ray | 200 A | A/B | 301-440 | PDB |
6DAT | X-ray | 235 A | A/B/C/D | 301-440 | PDB |
AF-P27577-F1 | Predicted | AlphaFoldDB |
1 variants for P27577
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs38156610 | 310 | D>E | No | Ensembl |
No associated diseases with P27577
9 regional properties for P27577
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Protein kinase domain | 270 - 523 | IPR000719 |
domain | SH2 domain | 146 - 245 | IPR000980 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 270 - 519 | IPR001245 |
domain | SH3 domain | 81 - 142 | IPR001452 |
active_site | Tyrosine-protein kinase, active site | 385 - 397 | IPR008266 |
binding_site | Protein kinase, ATP binding site | 276 - 298 | IPR017441 |
domain | Tyrosine-protein kinase, catalytic domain | 270 - 519 | IPR020635 |
domain | Fyn/Yrk, SH3 domain | 84 - 139 | IPR035750 |
domain | Fyn/Yrk, SH2 domain | 144 - 244 | IPR047924 |
Functions
Description | ||
---|---|---|
EC Number | ||
Subcellular Localization |
|
|
PANTHER Family | PTHR11849 | ETS |
PANTHER Subfamily | PTHR11849:SF209 | PROTEIN C-ETS-1 |
PANTHER Protein Class |
DNA-binding transcription factor
helix-turn-helix transcription factor winged helix/forkhead transcription factor |
|
PANTHER Pathway Category |
PDGF signaling pathway Ets Ras Pathway Ets VEGF signaling pathway Ets Angiogenesis Ets |
4 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
transcription regulator complex | A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. |
12 GO annotations of molecular function
Name | Definition |
---|---|
DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
DNA-binding transcription activator activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II. |
DNA-binding transcription factor activity | A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. |
DNA-binding transcription factor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
DNA-binding transcription factor binding | Binding to a DNA-binding transcription factor, a protein that interacts with a specific DNA sequence (sometimes referred to as a motif) within the regulatory region of a gene to modulate transcription. |
histone acetyltransferase binding | Binding to an histone acetyltransferase. |
identical protein binding | Binding to an identical protein or proteins. |
nuclear receptor coactivator activity | A transcription coactivator activity that activates or increases the transcription of specific gene sets via binding to a DNA-bound nuclear receptor, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator. |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
sequence-specific DNA binding | Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
sequence-specific double-stranded DNA binding | Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding. |
transcription cis-regulatory region binding | Binding to a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon. |
25 GO annotations of biological process
Name | Definition |
---|---|
cell differentiation | The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
cell motility | Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another. |
immune system process | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
negative regulation of cell cycle | Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. |
negative regulation of inflammatory response | Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
PML body organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of PML bodies, a class of nuclear body; they react against SP100 auto-antibodies (PML = promyelocytic leukemia). |
positive regulation of angiogenesis | Any process that activates or increases angiogenesis. |
positive regulation of blood vessel endothelial cell migration | Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels. |
positive regulation of cell migration | Any process that activates or increases the frequency, rate or extent of cell migration. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
positive regulation of cellular component movement | OBSOLETE. Any process that activates or increases the frequency, rate or extent of the movement of a cellular component. |
positive regulation of endothelial cell migration | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
positive regulation of erythrocyte differentiation | Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of inflammatory response | Any process that activates or increases the frequency, rate or extent of the inflammatory response. |
positive regulation of leukocyte adhesion to vascular endothelial cell | Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell. |
positive regulation of pri-miRNA transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
positive regulation of transcription, DNA-templated | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
regulation of angiogenesis | Any process that modulates the frequency, rate or extent of angiogenesis. |
regulation of apoptotic process | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
regulation of extracellular matrix disassembly | Any process that modulates the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
response to antibiotic | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms. |
transcription by RNA polymerase II | The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). |
40 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
A1A4L6 | ETS2 | Protein C-ets-2 | Bos taurus (Bovine) | SS |
Q2KIC2 | ETV1 | ETS translocation variant 1 | Bos taurus (Bovine) | SS |
P10157 | ETS2 | Protein C-ets-2 | Gallus gallus (Chicken) | SS |
Q90837 | ERG | Transcriptional regulator Erg | Gallus gallus (Chicken) | SS |
P13474 | ETS1 | Transforming protein p54/c-ets-1 | Gallus gallus (Chicken) | SS |
P15062 | ETS1 | Transforming protein p68/c-ets-1 | Gallus gallus (Chicken) | SS |
A2T762 | ETV3 | ETS translocation variant 3 | Pan troglodytes (Chimpanzee) | PR |
Q04688 | Ets97D | DNA-binding protein Ets97D | Drosophila melanogaster (Fruit fly) | PR |
P50548 | ERF | ETS domain-containing transcription factor ERF | Homo sapiens (Human) | PR |
P41970 | ELK3 | ETS domain-containing protein Elk-3 | Homo sapiens (Human) | SS |
P41161 | ETV5 | ETS translocation variant 5 | Homo sapiens (Human) | SS |
P43268 | ETV4 | ETS translocation variant 4 | Homo sapiens (Human) | EV |
Q06546 | GABPA | GA-binding protein alpha chain | Homo sapiens (Human) | SS |
P28324 | ELK4 | ETS domain-containing protein Elk-4 | Homo sapiens (Human) | EV |
P15036 | ETS2 | Protein C-ets-2 | Homo sapiens (Human) | EV |
P41162 | ETV3 | ETS translocation variant 3 | Homo sapiens (Human) | PR |
P50549 | ETV1 | ETS translocation variant 1 | Homo sapiens (Human) | EV |
P11308 | ERG | Transcriptional regulator ERG | Homo sapiens (Human) | EV |
P19419 | ELK1 | ETS domain-containing protein Elk-1 | Homo sapiens (Human) | EV |
P14921 | ETS1 | Protein C-ets-1 | Homo sapiens (Human) | EV |
P97360 | Etv6 | Transcription factor ETV6 | Mus musculus (Mouse) | EV |
Q8VDK3 | Elf5 | ETS-related transcription factor Elf-5 | Mus musculus (Mouse) | SS |
Q60775 | Elf1 | ETS-related transcription factor Elf-1 | Mus musculus (Mouse) | PR |
Q9Z2U4 | Elf4 | ETS-related transcription factor Elf-4 | Mus musculus (Mouse) | PR |
Q9JHC9 | Elf2 | ETS-related transcription factor Elf-2 | Mus musculus (Mouse) | PR |
Q00422 | Gabpa | GA-binding protein alpha chain | Mus musculus (Mouse) | EV |
Q9WTP3 | Spdef | SAM pointed domain-containing Ets transcription factor | Mus musculus (Mouse) | PR |
P70459 | Erf | ETS domain-containing transcription factor ERF | Mus musculus (Mouse) | PR |
P81270 | Erg | Transcriptional regulator ERG | Mus musculus (Mouse) | SS |
P28322 | Etv4 | ETS translocation variant 4 | Mus musculus (Mouse) | SS |
Q9CXC9 | Etv5 | ETS translocation variant 5 | Mus musculus (Mouse) | SS |
P41164 | Etv1 | ETS translocation variant 1 | Mus musculus (Mouse) | SS |
P41971 | Elk3 | ETS domain-containing protein Elk-3 | Mus musculus (Mouse) | EV |
P41158 | Elk4 | ETS domain-containing protein Elk-4 | Mus musculus (Mouse) | PR |
P41969 | Elk1 | ETS domain-containing protein Elk-1 | Mus musculus (Mouse) | PR |
P15037 | Ets2 | Protein C-ets-2 | Mus musculus (Mouse) | SS |
A4GTP4 | Elk1 | ETS domain-containing protein Elk-1 | Rattus norvegicus (Rat) | PR |
P41156 | Ets1 | Protein C-ets-1 | Rattus norvegicus (Rat) | SS |
Q9PUQ1 | etv4 | ETS translocation variant 4 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
A3FEM2 | fev | Protein FEV | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MKAAVDLKPT | LTIIKTEKVD | LELFPSPDME | CADVPLLTPS | SKEMMSQALK | ATFSGFTKEQ |
70 | 80 | 90 | 100 | 110 | 120 |
QRLGIPKDPR | QWTETHVRDW | VMWAVNEFSL | KGVDFQKFCM | SGAALCALGK | ECFLELAPDF |
130 | 140 | 150 | 160 | 170 | 180 |
VGDILWEHLE | ILQKEDVKPY | QVNGANPTYP | ESCYTSDYFI | SYGIEHAQCV | PPSEFSEPSF |
190 | 200 | 210 | 220 | 230 | 240 |
ITESYQTLHP | ISSEELLSLK | YENDYPSVIL | QDPLQTDTLQ | TDYFAIKQEV | LTPDNMCLGR |
250 | 260 | 270 | 280 | 290 | 300 |
ASRGKLGGQD | SFESVESYDS | CDRLTQSWSS | QSSFNSLQRV | PSYDSFDYED | YPAALPNHKP |
310 | 320 | 330 | 340 | 350 | 360 |
KGTFKDYVRD | RADLNKDKPV | IPAAALAGYT | GSGPIQLWQF | LLELLTDKSC | QSFISWTGDG |
370 | 380 | 390 | 400 | 410 | 420 |
WEFKLSDPDE | VARRWGKRKN | KPKMNYEKLS | RGLRYYYDKN | IIHKTAGKRY | VYRFVCDLQS |
430 | |||||
LLGYTPEELH | AMLDVKPDAD |